Jacob Friedman
Concepts (453)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity | 35 | 2023 | 2518 | 5.230 |
Why?
| Diabetes, Gestational | 18 | 2023 | 282 | 4.020 |
Why?
| Non-alcoholic Fatty Liver Disease | 11 | 2023 | 246 | 3.240 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 11 | 2018 | 32 | 3.230 |
Why?
| Maternal Nutritional Physiological Phenomena | 11 | 2021 | 141 | 3.020 |
Why?
| Fatty Liver | 12 | 2014 | 217 | 2.960 |
Why?
| Prenatal Exposure Delayed Effects | 13 | 2020 | 448 | 2.890 |
Why?
| Adiposity | 14 | 2023 | 468 | 2.360 |
Why?
| Liver | 22 | 2023 | 1690 | 2.350 |
Why?
| Pregnancy | 60 | 2023 | 5553 | 2.150 |
Why?
| Muscle, Skeletal | 15 | 2020 | 1447 | 2.020 |
Why?
| Diet, High-Fat | 8 | 2022 | 225 | 1.550 |
Why?
| Insulin | 25 | 2022 | 2082 | 1.400 |
Why?
| Insulin Resistance | 14 | 2023 | 1078 | 1.390 |
Why?
| Fatty Acids | 5 | 2017 | 386 | 1.380 |
Why?
| Pregnancy Complications | 7 | 2018 | 431 | 1.340 |
Why?
| Gastrointestinal Microbiome | 4 | 2020 | 503 | 1.330 |
Why?
| Fetus | 10 | 2023 | 702 | 1.330 |
Why?
| Adipogenesis | 4 | 2017 | 42 | 1.270 |
Why?
| Bone Marrow | 2 | 2023 | 249 | 1.260 |
Why?
| Prenatal Nutritional Physiological Phenomena | 5 | 2017 | 57 | 1.230 |
Why?
| Birth Weight | 7 | 2020 | 440 | 1.210 |
Why?
| Lipid Metabolism | 14 | 2023 | 449 | 1.190 |
Why?
| Fetal Development | 5 | 2018 | 247 | 1.100 |
Why?
| Epigenesis, Genetic | 5 | 2016 | 526 | 1.040 |
Why?
| Oxidative Stress | 9 | 2022 | 1093 | 1.020 |
Why?
| Glucose | 12 | 2023 | 904 | 1.000 |
Why?
| DNA Methylation | 6 | 2023 | 499 | 1.000 |
Why?
| Fetal Growth Retardation | 8 | 2019 | 466 | 0.950 |
Why?
| Microbiota | 4 | 2022 | 653 | 0.950 |
Why?
| Inflammation | 10 | 2018 | 2500 | 0.940 |
Why?
| Diet, Western | 6 | 2023 | 66 | 0.940 |
Why?
| AMP-Activated Protein Kinases | 4 | 2023 | 175 | 0.930 |
Why?
| Animals | 51 | 2023 | 32104 | 0.890 |
Why?
| Female | 70 | 2023 | 60018 | 0.880 |
Why?
| Sirtuin 3 | 3 | 2013 | 52 | 0.870 |
Why?
| Dietary Fats | 4 | 2017 | 289 | 0.860 |
Why?
| Energy Metabolism | 8 | 2019 | 715 | 0.850 |
Why?
| PPAR gamma | 5 | 2017 | 185 | 0.820 |
Why?
| Macrophages | 6 | 2016 | 1284 | 0.810 |
Why?
| Umbilical Cord | 3 | 2017 | 80 | 0.800 |
Why?
| Mitochondria | 7 | 2020 | 750 | 0.780 |
Why?
| Breast Feeding | 3 | 2020 | 370 | 0.770 |
Why?
| Gluconeogenesis | 8 | 2018 | 60 | 0.760 |
Why?
| Phosphoenolpyruvate Carboxykinase (GTP) | 3 | 2012 | 31 | 0.750 |
Why?
| Infant, Newborn | 17 | 2023 | 5061 | 0.740 |
Why?
| Fatty Acids, Omega-3 | 3 | 2022 | 124 | 0.730 |
Why?
| Infant Formula | 1 | 2020 | 74 | 0.700 |
Why?
| Hematopoietic Stem Cells | 1 | 2023 | 346 | 0.700 |
Why?
| Child Nutritional Physiological Phenomena | 1 | 2020 | 97 | 0.690 |
Why?
| Fatty Acid Desaturases | 1 | 2020 | 30 | 0.680 |
Why?
| Maternal Exposure | 2 | 2021 | 138 | 0.670 |
Why?
| Transgenes | 1 | 2020 | 169 | 0.660 |
Why?
| Amino Acids | 4 | 2017 | 454 | 0.640 |
Why?
| Mothers | 6 | 2018 | 666 | 0.630 |
Why?
| Endoplasmic Reticulum | 3 | 2010 | 235 | 0.630 |
Why?
| PQQ Cofactor | 2 | 2022 | 5 | 0.620 |
Why?
| Macrophage Activation | 3 | 2014 | 165 | 0.600 |
Why?
| Muscle Proteins | 2 | 2014 | 209 | 0.600 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2020 | 180 | 0.600 |
Why?
| Diet | 5 | 2022 | 1074 | 0.580 |
Why?
| Mice | 21 | 2020 | 15052 | 0.580 |
Why?
| Triglycerides | 8 | 2023 | 473 | 0.580 |
Why?
| Pediatric Obesity | 3 | 2022 | 493 | 0.580 |
Why?
| Fatty Acids, Omega-6 | 2 | 2017 | 46 | 0.580 |
Why?
| Adenylate Kinase | 3 | 2014 | 27 | 0.570 |
Why?
| Metabolic Diseases | 2 | 2017 | 99 | 0.560 |
Why?
| Gene Expression Regulation | 9 | 2019 | 2353 | 0.550 |
Why?
| Blood Glucose | 11 | 2023 | 1824 | 0.550 |
Why?
| Hyperlipidemias | 2 | 2016 | 124 | 0.540 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 2012 | 332 | 0.540 |
Why?
| Niacinamide | 1 | 2016 | 65 | 0.530 |
Why?
| Humans | 56 | 2023 | 115741 | 0.520 |
Why?
| Adipose Tissue | 5 | 2018 | 555 | 0.520 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2015 | 77 | 0.510 |
Why?
| Mitochondrial Proteins | 2 | 2014 | 219 | 0.500 |
Why?
| Infant | 11 | 2022 | 7979 | 0.500 |
Why?
| Metabolomics | 3 | 2017 | 538 | 0.480 |
Why?
| Gene Expression | 3 | 2017 | 1436 | 0.480 |
Why?
| Antioxidants | 2 | 2023 | 533 | 0.470 |
Why?
| Cholesterol | 1 | 2016 | 369 | 0.470 |
Why?
| Fenofibrate | 2 | 2016 | 24 | 0.470 |
Why?
| Placenta | 5 | 2021 | 624 | 0.460 |
Why?
| beta Catenin | 1 | 2015 | 220 | 0.460 |
Why?
| Insulin Receptor Substrate Proteins | 4 | 2011 | 56 | 0.450 |
Why?
| Diabetes Mellitus, Type 2 | 5 | 2022 | 2098 | 0.450 |
Why?
| Carcinoma, Hepatocellular | 3 | 2010 | 224 | 0.440 |
Why?
| Electron Transport Complex II | 1 | 2013 | 23 | 0.440 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2010 | 15 | 0.440 |
Why?
| Hepacivirus | 2 | 2012 | 234 | 0.440 |
Why?
| Macaca | 4 | 2018 | 51 | 0.430 |
Why?
| Orphan Nuclear Receptors | 1 | 2012 | 14 | 0.430 |
Why?
| Hydrocarbons, Fluorinated | 1 | 2012 | 9 | 0.430 |
Why?
| Calcium Signaling | 1 | 2014 | 211 | 0.420 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2017 | 794 | 0.420 |
Why?
| Mitochondria, Liver | 1 | 2012 | 66 | 0.410 |
Why?
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.410 |
Why?
| Hypoxia | 1 | 2018 | 937 | 0.410 |
Why?
| Atherosclerosis | 1 | 2016 | 342 | 0.410 |
Why?
| Viral Nonstructural Proteins | 1 | 2012 | 56 | 0.400 |
Why?
| Adipose Tissue, Brown | 1 | 2012 | 68 | 0.400 |
Why?
| Genome, Viral | 1 | 2012 | 121 | 0.390 |
Why?
| Superoxide Dismutase | 1 | 2013 | 332 | 0.380 |
Why?
| MicroRNAs | 2 | 2020 | 607 | 0.380 |
Why?
| Sheep | 8 | 2023 | 765 | 0.370 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2011 | 36 | 0.370 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 129 | 0.370 |
Why?
| Glucose Tolerance Test | 6 | 2018 | 344 | 0.370 |
Why?
| Signal Transduction | 12 | 2020 | 4541 | 0.360 |
Why?
| Male | 23 | 2020 | 56050 | 0.350 |
Why?
| Metformin | 3 | 2023 | 278 | 0.350 |
Why?
| Pre-Eclampsia | 1 | 2012 | 165 | 0.350 |
Why?
| Lipids | 5 | 2017 | 588 | 0.340 |
Why?
| Phosphorylation | 8 | 2021 | 1571 | 0.340 |
Why?
| Receptors, Adiponectin | 1 | 2009 | 14 | 0.340 |
Why?
| Hyperglycemia | 2 | 2020 | 295 | 0.340 |
Why?
| Glucose Intolerance | 1 | 2011 | 137 | 0.330 |
Why?
| Phenylbutyrates | 1 | 2009 | 21 | 0.330 |
Why?
| Liver Neoplasms | 2 | 2010 | 521 | 0.330 |
Why?
| Adult | 22 | 2022 | 30789 | 0.330 |
Why?
| Sulfonamides | 1 | 2012 | 447 | 0.330 |
Why?
| Body Mass Index | 8 | 2022 | 1971 | 0.330 |
Why?
| RNA, Messenger | 6 | 2017 | 2574 | 0.330 |
Why?
| Biomarkers | 8 | 2023 | 3471 | 0.320 |
Why?
| Dietary Supplements | 5 | 2022 | 458 | 0.310 |
Why?
| Up-Regulation | 2 | 2010 | 820 | 0.300 |
Why?
| Primates | 3 | 2023 | 111 | 0.300 |
Why?
| Diet, Fat-Restricted | 3 | 2023 | 73 | 0.290 |
Why?
| Haplorhini | 2 | 2018 | 60 | 0.290 |
Why?
| Mice, Inbred C57BL | 6 | 2018 | 4773 | 0.280 |
Why?
| Mammary Glands, Human | 2 | 2020 | 60 | 0.280 |
Why?
| Carnitine | 2 | 2017 | 61 | 0.270 |
Why?
| Postprandial Period | 3 | 2018 | 88 | 0.270 |
Why?
| Oxidation-Reduction | 4 | 2017 | 924 | 0.270 |
Why?
| Preconception Care | 2 | 2018 | 31 | 0.270 |
Why?
| Muscle Development | 2 | 2017 | 93 | 0.270 |
Why?
| Lactation | 2 | 2020 | 149 | 0.270 |
Why?
| Electron Transport | 2 | 2017 | 112 | 0.260 |
Why?
| Milk, Human | 2 | 2020 | 128 | 0.260 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2007 | 1137 | 0.260 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2012 | 128 | 0.260 |
Why?
| Cytokines | 6 | 2018 | 1853 | 0.250 |
Why?
| JNK Mitogen-Activated Protein Kinases | 3 | 2012 | 146 | 0.250 |
Why?
| Amino Acids, Branched-Chain | 2 | 2018 | 32 | 0.240 |
Why?
| Diet, Diabetic | 2 | 2015 | 33 | 0.240 |
Why?
| Enzyme Activation | 3 | 2012 | 793 | 0.240 |
Why?
| Hepatocytes | 3 | 2023 | 197 | 0.230 |
Why?
| Cell Line, Tumor | 5 | 2014 | 2751 | 0.230 |
Why?
| Postpartum Period | 4 | 2020 | 281 | 0.230 |
Why?
| Glucokinase | 1 | 2003 | 12 | 0.230 |
Why?
| Lipoprotein Lipase | 2 | 2018 | 55 | 0.230 |
Why?
| Mice, Knockout | 6 | 2014 | 2604 | 0.220 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2016 | 145 | 0.220 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2003 | 44 | 0.220 |
Why?
| Prolactin | 1 | 2003 | 95 | 0.220 |
Why?
| Cyclic AMP | 1 | 2003 | 227 | 0.210 |
Why?
| Blotting, Western | 5 | 2019 | 1153 | 0.210 |
Why?
| Bifidobacterium | 1 | 2022 | 21 | 0.210 |
Why?
| Glucose Clamp Technique | 3 | 2019 | 181 | 0.200 |
Why?
| Longitudinal Studies | 3 | 2020 | 2420 | 0.200 |
Why?
| Progesterone | 1 | 2003 | 232 | 0.200 |
Why?
| Glycerol | 1 | 2022 | 86 | 0.200 |
Why?
| Mice, Transgenic | 2 | 2020 | 1970 | 0.200 |
Why?
| Cell Differentiation | 4 | 2017 | 1700 | 0.200 |
Why?
| Insulins | 1 | 2022 | 32 | 0.200 |
Why?
| Forkhead Transcription Factors | 2 | 2012 | 171 | 0.190 |
Why?
| Dexamethasone | 1 | 2003 | 316 | 0.190 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.190 |
Why?
| Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.190 |
Why?
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 42 | 0.190 |
Why?
| Child | 9 | 2023 | 18503 | 0.180 |
Why?
| Response Elements | 2 | 2011 | 83 | 0.180 |
Why?
| Thapsigargin | 2 | 2010 | 18 | 0.180 |
Why?
| Risk Factors | 6 | 2022 | 8702 | 0.170 |
Why?
| Liver Cirrhosis | 1 | 2021 | 238 | 0.170 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 263 | 0.170 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2019 | 930 | 0.170 |
Why?
| Body Composition | 5 | 2017 | 580 | 0.170 |
Why?
| Carnitine O-Palmitoyltransferase | 2 | 2017 | 43 | 0.170 |
Why?
| Phenotype | 4 | 2023 | 2839 | 0.170 |
Why?
| Immune System | 1 | 2020 | 173 | 0.160 |
Why?
| Promoter Regions, Genetic | 3 | 2017 | 1122 | 0.160 |
Why?
| Diabetes Mellitus | 1 | 2007 | 908 | 0.160 |
Why?
| Germ-Free Life | 1 | 2018 | 30 | 0.160 |
Why?
| Culture Media, Conditioned | 2 | 2016 | 105 | 0.160 |
Why?
| Citric Acid Cycle | 1 | 2018 | 42 | 0.160 |
Why?
| Insulin-Like Growth Factor I | 1 | 2021 | 281 | 0.160 |
Why?
| Fatty Acids, Volatile | 1 | 2018 | 47 | 0.160 |
Why?
| PPAR alpha | 3 | 2022 | 52 | 0.160 |
Why?
| Gene Expression Profiling | 4 | 2019 | 1537 | 0.160 |
Why?
| Rats | 4 | 2012 | 5033 | 0.150 |
Why?
| Fetal Macrosomia | 1 | 2018 | 58 | 0.150 |
Why?
| Micronutrients | 1 | 2018 | 77 | 0.150 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.150 |
Why?
| Bile Acids and Salts | 1 | 2018 | 172 | 0.150 |
Why?
| Muscle Cells | 1 | 2017 | 41 | 0.150 |
Why?
| Niacin | 1 | 2017 | 19 | 0.150 |
Why?
| Islets of Langerhans | 1 | 2003 | 729 | 0.150 |
Why?
| Immunity, Innate | 1 | 2023 | 731 | 0.150 |
Why?
| Hypoglycemic Agents | 3 | 2018 | 1008 | 0.140 |
Why?
| Bone Marrow Cells | 2 | 2016 | 268 | 0.140 |
Why?
| Dysbiosis | 1 | 2018 | 146 | 0.140 |
Why?
| Mitochondrial Diseases | 1 | 2017 | 77 | 0.140 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 400 | 0.140 |
Why?
| Computational Biology | 1 | 2020 | 537 | 0.140 |
Why?
| Caenorhabditis elegans | 1 | 2020 | 271 | 0.140 |
Why?
| Mice, Knockout, ApoE | 1 | 2016 | 8 | 0.140 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2016 | 160 | 0.140 |
Why?
| Sirtuin 1 | 1 | 2016 | 29 | 0.140 |
Why?
| Foam Cells | 1 | 2016 | 13 | 0.140 |
Why?
| Myoblasts | 1 | 2017 | 74 | 0.130 |
Why?
| Feces | 1 | 2018 | 372 | 0.130 |
Why?
| Gestational Age | 5 | 2019 | 758 | 0.130 |
Why?
| Ceramides | 1 | 2016 | 96 | 0.130 |
Why?
| RAW 264.7 Cells | 1 | 2016 | 41 | 0.130 |
Why?
| Colitis | 1 | 2018 | 226 | 0.130 |
Why?
| Plethysmography | 1 | 2016 | 103 | 0.130 |
Why?
| Cyclooxygenase 2 | 1 | 2016 | 164 | 0.130 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2018 | 342 | 0.130 |
Why?
| Nutritional Status | 2 | 2018 | 289 | 0.130 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2015 | 60 | 0.130 |
Why?
| Gene Deletion | 2 | 2018 | 355 | 0.130 |
Why?
| Interleukin-6 | 2 | 2016 | 677 | 0.130 |
Why?
| Cohort Studies | 3 | 2015 | 4949 | 0.130 |
Why?
| Cells, Cultured | 4 | 2016 | 3914 | 0.130 |
Why?
| Gene Silencing | 1 | 2016 | 175 | 0.130 |
Why?
| Muscle Fibers, Skeletal | 1 | 2016 | 169 | 0.120 |
Why?
| 3T3-L1 Cells | 2 | 2012 | 31 | 0.120 |
Why?
| Space Flight | 1 | 2016 | 123 | 0.120 |
Why?
| Glucose-6-Phosphatase | 2 | 2012 | 31 | 0.120 |
Why?
| Adolescent | 7 | 2023 | 17922 | 0.120 |
Why?
| Hematopoiesis | 1 | 2016 | 173 | 0.120 |
Why?
| Cell Division | 1 | 2017 | 759 | 0.120 |
Why?
| Young Adult | 7 | 2018 | 10518 | 0.120 |
Why?
| Awards and Prizes | 1 | 2015 | 56 | 0.120 |
Why?
| Inflammatory Bowel Diseases | 1 | 2018 | 289 | 0.120 |
Why?
| Bacteria | 1 | 2020 | 729 | 0.120 |
Why?
| Endocrinology | 1 | 2015 | 69 | 0.120 |
Why?
| Maternal Welfare | 1 | 2014 | 15 | 0.120 |
Why?
| Overweight | 2 | 2015 | 469 | 0.120 |
Why?
| Glucose Transporter Type 4 | 2 | 2006 | 36 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 795 | 0.120 |
Why?
| Animal Feed | 1 | 2014 | 50 | 0.110 |
Why?
| Maternal-Fetal Exchange | 1 | 2015 | 151 | 0.110 |
Why?
| Intestinal Mucosa | 1 | 2018 | 528 | 0.110 |
Why?
| Nutrition Assessment | 1 | 2014 | 75 | 0.110 |
Why?
| Body Weight | 4 | 2016 | 867 | 0.110 |
Why?
| Dietary Fiber | 1 | 2013 | 40 | 0.110 |
Why?
| Disease Progression | 1 | 2020 | 2423 | 0.110 |
Why?
| Disease Models, Animal | 3 | 2019 | 3580 | 0.110 |
Why?
| Intestines | 2 | 2013 | 324 | 0.110 |
Why?
| Polymerase Chain Reaction | 1 | 2016 | 1001 | 0.110 |
Why?
| Dietary Carbohydrates | 1 | 2014 | 135 | 0.110 |
Why?
| Sheep, Domestic | 2 | 2019 | 33 | 0.110 |
Why?
| Cell Proliferation | 2 | 2017 | 2194 | 0.110 |
Why?
| Liver X Receptors | 1 | 2012 | 30 | 0.110 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2018 | 965 | 0.110 |
Why?
| MAP Kinase Kinase 4 | 1 | 2012 | 23 | 0.110 |
Why?
| Forkhead Box Protein O1 | 1 | 2012 | 14 | 0.100 |
Why?
| Secretory Vesicles | 1 | 2012 | 24 | 0.100 |
Why?
| Enzyme Induction | 1 | 2012 | 85 | 0.100 |
Why?
| Adipocytes | 2 | 2017 | 188 | 0.100 |
Why?
| Antigens, Differentiation | 1 | 2012 | 79 | 0.100 |
Why?
| Lipogenesis | 1 | 2012 | 57 | 0.100 |
Why?
| Luciferases | 1 | 2012 | 140 | 0.100 |
Why?
| Mice, Mutant Strains | 1 | 2012 | 271 | 0.100 |
Why?
| Transcription Factor RelA | 1 | 2012 | 83 | 0.100 |
Why?
| Endotoxins | 2 | 2023 | 207 | 0.100 |
Why?
| Cholesterol, HDL | 1 | 2012 | 185 | 0.100 |
Why?
| Glutathione | 1 | 2013 | 303 | 0.100 |
Why?
| Genes, Reporter | 1 | 2012 | 257 | 0.100 |
Why?
| Receptor, Insulin | 4 | 2007 | 93 | 0.100 |
Why?
| Colorado | 2 | 2020 | 4116 | 0.100 |
Why?
| Retinoid X Receptor alpha | 1 | 2011 | 4 | 0.100 |
Why?
| Prenatal Care | 1 | 2014 | 258 | 0.100 |
Why?
| Risk Assessment | 1 | 2020 | 2990 | 0.100 |
Why?
| Membrane Proteins | 1 | 2017 | 1024 | 0.100 |
Why?
| Morphogenesis | 1 | 2012 | 161 | 0.100 |
Why?
| Random Allocation | 3 | 2023 | 337 | 0.100 |
Why?
| Proteomics | 2 | 2014 | 859 | 0.090 |
Why?
| Inflammasomes | 1 | 2012 | 116 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2022 | 1729 | 0.090 |
Why?
| Practice Guidelines as Topic | 1 | 2018 | 1405 | 0.090 |
Why?
| Hydrocortisone | 1 | 2012 | 273 | 0.090 |
Why?
| Adipocytes, White | 1 | 2010 | 17 | 0.090 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2012 | 483 | 0.090 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2011 | 185 | 0.090 |
Why?
| NAD | 1 | 2011 | 67 | 0.090 |
Why?
| Interleukin-10 | 1 | 2012 | 299 | 0.090 |
Why?
| Serine | 1 | 2011 | 125 | 0.090 |
Why?
| Tyrosine | 1 | 2011 | 219 | 0.090 |
Why?
| Virus Replication | 1 | 2012 | 396 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 274 | 0.090 |
Why?
| Caloric Restriction | 1 | 2011 | 90 | 0.090 |
Why?
| Cell Line | 2 | 2007 | 2651 | 0.090 |
Why?
| Fibroblasts | 1 | 2014 | 839 | 0.080 |
Why?
| Tunicamycin | 1 | 2009 | 11 | 0.080 |
Why?
| Mesoderm | 1 | 2010 | 138 | 0.080 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2009 | 34 | 0.080 |
Why?
| Myeloid Cells | 1 | 2010 | 127 | 0.080 |
Why?
| Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.080 |
Why?
| CREB-Binding Protein | 1 | 2008 | 27 | 0.080 |
Why?
| Cyclin D1 | 1 | 2008 | 61 | 0.080 |
Why?
| Hypolipidemic Agents | 1 | 2009 | 87 | 0.080 |
Why?
| Animals, Newborn | 3 | 2017 | 780 | 0.080 |
Why?
| Time Factors | 3 | 2012 | 6171 | 0.080 |
Why?
| Carrier Proteins | 1 | 2012 | 701 | 0.080 |
Why?
| Child Development | 1 | 2012 | 390 | 0.080 |
Why?
| Placental Insufficiency | 1 | 2009 | 102 | 0.070 |
Why?
| Protein Binding | 2 | 2010 | 1917 | 0.070 |
Why?
| Wnt Proteins | 1 | 2008 | 135 | 0.070 |
Why?
| Models, Genetic | 1 | 2010 | 570 | 0.070 |
Why?
| Choline Deficiency | 1 | 2007 | 11 | 0.070 |
Why?
| Acute-Phase Reaction | 1 | 2007 | 39 | 0.070 |
Why?
| Cytochrome P-450 CYP2E1 | 1 | 2007 | 27 | 0.070 |
Why?
| eIF-2 Kinase | 1 | 2007 | 24 | 0.070 |
Why?
| Palmitates | 1 | 2007 | 16 | 0.070 |
Why?
| Eukaryotic Initiation Factor-2 | 1 | 2007 | 23 | 0.070 |
Why?
| Transcription Factor CHOP | 1 | 2007 | 28 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2017 | 1870 | 0.070 |
Why?
| Stress, Physiological | 1 | 2010 | 399 | 0.070 |
Why?
| Age Factors | 2 | 2011 | 2911 | 0.070 |
Why?
| Histones | 1 | 2012 | 540 | 0.070 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 54 | 0.070 |
Why?
| Ribosomal Protein S6 Kinases | 2 | 2008 | 21 | 0.070 |
Why?
| Stearoyl-CoA Desaturase | 1 | 2007 | 53 | 0.070 |
Why?
| Fibrosis | 2 | 2023 | 457 | 0.070 |
Why?
| Phosphoproteins | 3 | 2006 | 304 | 0.070 |
Why?
| Lipase | 1 | 2007 | 66 | 0.070 |
Why?
| Hormones | 1 | 2007 | 132 | 0.070 |
Why?
| Methionine | 1 | 2007 | 145 | 0.070 |
Why?
| Adiponectin | 2 | 2018 | 214 | 0.070 |
Why?
| Proteins | 1 | 2012 | 920 | 0.070 |
Why?
| Glucose Transporter Type 1 | 1 | 2006 | 42 | 0.070 |
Why?
| Reference Values | 1 | 2007 | 750 | 0.060 |
Why?
| Pilot Projects | 2 | 2023 | 1384 | 0.060 |
Why?
| Fasting | 2 | 2018 | 241 | 0.060 |
Why?
| Genetic Predisposition to Disease | 1 | 2013 | 2129 | 0.060 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 1147 | 0.060 |
Why?
| RNA | 1 | 2011 | 820 | 0.060 |
Why?
| Protein Kinase Inhibitors | 1 | 2010 | 790 | 0.060 |
Why?
| Glycemic Index | 2 | 2015 | 21 | 0.060 |
Why?
| Insulin Antagonists | 1 | 2003 | 6 | 0.060 |
Why?
| Fatty Acids, Nonesterified | 2 | 2015 | 151 | 0.060 |
Why?
| Keto Acids | 1 | 2003 | 12 | 0.060 |
Why?
| NF-kappa B | 1 | 2007 | 639 | 0.050 |
Why?
| Hypertension, Pulmonary | 1 | 2014 | 1754 | 0.050 |
Why?
| Leptin | 2 | 2018 | 211 | 0.050 |
Why?
| Prospective Studies | 3 | 2022 | 6276 | 0.050 |
Why?
| C-Peptide | 1 | 2023 | 138 | 0.050 |
Why?
| Drug Synergism | 1 | 2003 | 317 | 0.050 |
Why?
| TOR Serine-Threonine Kinases | 2 | 2020 | 362 | 0.050 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2020 | 1218 | 0.050 |
Why?
| Monosaccharide Transport Proteins | 1 | 2002 | 45 | 0.050 |
Why?
| Fetal Blood | 1 | 2023 | 268 | 0.050 |
Why?
| Mammals | 1 | 2023 | 251 | 0.050 |
Why?
| Magnetic Resonance Imaging | 1 | 2012 | 3122 | 0.050 |
Why?
| Longevity | 1 | 2022 | 137 | 0.050 |
Why?
| Aging | 1 | 2011 | 1632 | 0.050 |
Why?
| Myocardium | 1 | 2006 | 926 | 0.050 |
Why?
| Uterus | 1 | 2021 | 193 | 0.050 |
Why?
| Skinfold Thickness | 1 | 2020 | 48 | 0.040 |
Why?
| Models, Biological | 2 | 2010 | 1646 | 0.040 |
Why?
| Follow-Up Studies | 2 | 2022 | 4442 | 0.040 |
Why?
| Transcription Factors | 1 | 2007 | 1528 | 0.040 |
Why?
| Patient Compliance | 2 | 2014 | 524 | 0.040 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2020 | 92 | 0.040 |
Why?
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 21 | 0.040 |
Why?
| Glucocorticoids | 1 | 2003 | 552 | 0.040 |
Why?
| Biological Transport | 1 | 2020 | 375 | 0.040 |
Why?
| Single-Cell Analysis | 1 | 2020 | 188 | 0.040 |
Why?
| In Vitro Techniques | 1 | 2021 | 1044 | 0.040 |
Why?
| Lipopolysaccharides | 1 | 2022 | 826 | 0.040 |
Why?
| Protein Biosynthesis | 2 | 2012 | 390 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2022 | 781 | 0.040 |
Why?
| Cell Membrane | 1 | 2002 | 683 | 0.040 |
Why?
| Perilipin-1 | 1 | 2017 | 16 | 0.040 |
Why?
| Pregnancy Trimester, First | 1 | 2018 | 127 | 0.040 |
Why?
| Cell Size | 1 | 2017 | 81 | 0.040 |
Why?
| Treatment Outcome | 3 | 2018 | 9162 | 0.040 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2017 | 63 | 0.040 |
Why?
| Guatemala | 1 | 2018 | 268 | 0.040 |
Why?
| Diet Surveys | 1 | 2017 | 78 | 0.040 |
Why?
| Flow Cytometry | 1 | 2020 | 1083 | 0.040 |
Why?
| Child, Preschool | 2 | 2021 | 9138 | 0.030 |
Why?
| Hepatic Stellate Cells | 1 | 2016 | 10 | 0.030 |
Why?
| Stem Cells | 1 | 2020 | 546 | 0.030 |
Why?
| Lipid Droplets | 1 | 2016 | 21 | 0.030 |
Why?
| Obstetrics | 1 | 2018 | 161 | 0.030 |
Why?
| Down-Regulation | 1 | 2018 | 601 | 0.030 |
Why?
| Systems Biology | 1 | 2016 | 57 | 0.030 |
Why?
| Lactates | 1 | 2015 | 83 | 0.030 |
Why?
| Energy Intake | 1 | 2017 | 414 | 0.030 |
Why?
| Epithelial Cells | 1 | 2020 | 961 | 0.030 |
Why?
| Rats, Inbred WKY | 1 | 2014 | 32 | 0.030 |
Why?
| Health | 1 | 2015 | 74 | 0.030 |
Why?
| Societies, Medical | 1 | 2018 | 684 | 0.030 |
Why?
| Democratic Republic of the Congo | 1 | 2014 | 22 | 0.030 |
Why?
| Pakistan | 1 | 2014 | 72 | 0.030 |
Why?
| Immunoblotting | 1 | 2014 | 281 | 0.030 |
Why?
| Dietary Sucrose | 1 | 2013 | 45 | 0.030 |
Why?
| Transcriptome | 1 | 2019 | 736 | 0.030 |
Why?
| Prediabetic State | 1 | 2016 | 225 | 0.030 |
Why?
| Fructose | 1 | 2013 | 100 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2018 | 1825 | 0.030 |
Why?
| STAT3 Transcription Factor | 1 | 2014 | 174 | 0.030 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 249 | 0.030 |
Why?
| Cross-Over Studies | 1 | 2014 | 435 | 0.030 |
Why?
| Carbon Isotopes | 1 | 2012 | 110 | 0.020 |
Why?
| Leucine | 1 | 2012 | 108 | 0.020 |
Why?
| Proteolysis | 1 | 2012 | 145 | 0.020 |
Why?
| Mammary Glands, Animal | 1 | 2012 | 116 | 0.020 |
Why?
| Cattle | 1 | 2014 | 935 | 0.020 |
Why?
| Pyruvate Dehydrogenase Complex | 1 | 2011 | 8 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2014 | 1168 | 0.020 |
Why?
| Milk | 1 | 2012 | 124 | 0.020 |
Why?
| Pregnancy Outcome | 1 | 2013 | 337 | 0.020 |
Why?
| Hep G2 Cells | 1 | 2011 | 61 | 0.020 |
Why?
| Triiodothyronine | 1 | 2011 | 43 | 0.020 |
Why?
| Cell Respiration | 1 | 2011 | 74 | 0.020 |
Why?
| Case-Control Studies | 1 | 2018 | 3037 | 0.020 |
Why?
| Adipocytes, Brown | 1 | 2010 | 6 | 0.020 |
Why?
| Cytogenetic Analysis | 1 | 2010 | 29 | 0.020 |
Why?
| Prognosis | 1 | 2018 | 3343 | 0.020 |
Why?
| Disease Susceptibility | 1 | 2012 | 316 | 0.020 |
Why?
| Acetylation | 1 | 2011 | 212 | 0.020 |
Why?
| Motor Activity | 1 | 2014 | 633 | 0.020 |
Why?
| Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.020 |
Why?
| Somatostatin | 1 | 2008 | 53 | 0.020 |
Why?
| Cell Lineage | 1 | 2010 | 310 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 746 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2018 | 4448 | 0.020 |
Why?
| Liver Glycogen | 1 | 2007 | 19 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 147 | 0.020 |
Why?
| Oncogene Protein v-akt | 1 | 2007 | 26 | 0.020 |
Why?
| Absorptiometry, Photon | 1 | 2008 | 221 | 0.020 |
Why?
| Hyperinsulinism | 1 | 2008 | 103 | 0.020 |
Why?
| Cloning, Molecular | 1 | 2007 | 523 | 0.020 |
Why?
| Protein Kinases | 1 | 2008 | 306 | 0.020 |
Why?
| Biomedical Research | 1 | 2012 | 589 | 0.020 |
Why?
| Glycogen | 1 | 2006 | 52 | 0.020 |
Why?
| Binding Sites | 1 | 2008 | 1177 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2012 | 2824 | 0.020 |
Why?
| Organ Size | 1 | 2006 | 434 | 0.020 |
Why?
| Sex Factors | 1 | 2010 | 1739 | 0.020 |
Why?
| Fever | 1 | 2006 | 280 | 0.020 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 388 | 0.010 |
Why?
| Hypoglycemia | 1 | 2007 | 386 | 0.010 |
Why?
| United States | 1 | 2018 | 12304 | 0.010 |
Why?
| Aged | 1 | 2016 | 19294 | 0.010 |
Why?
| Mutation | 1 | 2008 | 3364 | 0.010 |
Why?
| Retrospective Studies | 1 | 2014 | 12633 | 0.010 |
Why?
| Middle Aged | 1 | 2016 | 27069 | 0.010 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|